Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor subtypes
Lin SK, Tsai SM, Huang JC, Lee SC, Wu SH, Wu SH, et al
Moreover, this model benefits from integrating multiple data streams, including patient-reported outcomes, wearable sensors, and laboratory diagnostics
Sikiric P, Gojkovic S, Krezic I, Smoday IM, Kalogjera L, Zizek H, Oroz K, Vranes H, Vukovic V, Labidi M, Strbe S, Baketic Oreskovic L, Sever M, Tepes M, Knezevic M, Barisic I, Blagaic V, Vlainic J, Dobric I, Staresinic M, Skrtic A, Jurjevic I, Boban Blagaic A, Seiwerth S
The clinical significance of these findings is not known
2017 Cell study used 5 mg/kg intraperitoneal injection three times per week in aged mice, with treatment periods of several weeks the three-times-weekly dosing suggests the peptide maintains sufficient functional concentrations for at least 48-72 hours per dose (PMID: 28340339)